The In Vitro and In Vivo Effect of Lipoxygenase Pathway Inhibitors Nordihydroguaiaretic Acid and Its Derivative Tetra-O-methyl Nordihydroguaiaretic Acid against Brucella abortus 544
暂无分享,去创建一个
Dongho Lee | John-hwa Lee | J. Hur | Suk Kim | T. X. N. Huy | W. Min | Trang T. Nguyen | Heejin Kim | A. Reyes | T. Nguyen
[1] Å. Lundkvist,et al. Using a One Health Case-Based Investigation for Improved Control of Brucellosis in Isiolo, Kenya , 2021, Frontiers in Tropical Diseases.
[2] A. Rehman,et al. Animal and Human Brucellosis in Pakistan , 2021, Frontiers in Public Health.
[3] Bei Wang,et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets , 2021, Signal Transduction and Targeted Therapy.
[4] John-hwa Lee,et al. Formyl peptide receptor 2 (FPR2) antagonism is a potential target for the prevention of Brucella abortus 544 infection. , 2021, Immunobiology.
[5] R. Tiwari,et al. Importance of brucellosis control programs of livestock on the improvement of one health , 2021, The veterinary quarterly.
[6] John-hwa Lee,et al. Prostaglandin I2 (PGI2) inhibits Brucella abortus internalization in macrophages via PGI2 receptor signaling, and its analogue affects immune response and disease outcome in mice. , 2020, Developmental and comparative immunology.
[7] D. Comerci,et al. Brucella abortus Depends on l-Serine Biosynthesis for Intracellular Proliferation , 2019, Infection and Immunity.
[8] John-hwa Lee,et al. Chemokine receptor 4 (CXCR4) blockade enhances resistance to bacterial internalization in RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates susceptibility to Brucella abortus 544 infection in a murine model. , 2019, Veterinary microbiology.
[9] S. Bicciato,et al. Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism , 2019, Nature Communications.
[10] H. Tallima,et al. Arachidonic acid: Physiological roles and potential health benefits – A review , 2017, Journal of advanced research.
[11] T. Yokomizo,et al. Identification, signaling, and functions of LTB4 receptors. , 2017, Seminars in immunology.
[12] J. Saiz,et al. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-O-Methyl Nordihydroguaiaretic Acid against West Nile Virus and Zika Virus , 2017, Antimicrobial Agents and Chemotherapy.
[13] J. Mege,et al. COX-2 Inhibition Reduces Brucella Bacterial Burden in Draining Lymph Nodes , 2016, Front. Microbiol..
[14] Tomoaki Koga,et al. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] Yanmin Hu,et al. Nordihydroguaiaretic acid enhances the activities of aminoglycosides against methicillin- sensitive and resistant Staphylococcus aureus in vitro and in vivo , 2015, Front. Microbiol..
[16] N. Demirkan,et al. Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors. , 2015, Journal of infection in developing countries.
[17] M. Caliari,et al. 5-Lipoxygenase Negatively Regulates Th1 Response during Brucella abortus Infection in Mice , 2015, Infection and Immunity.
[18] V. Azevedo,et al. Lack of Endogenous IL-10 Enhances Production of Proinflammatory Cytokines and Leads to Brucella abortus Clearance in Mice , 2013, PloS one.
[19] A. Brunet,et al. Leukotriene B4, an Endogenous Stimulator of the Innate Immune Response against Pathogens , 2013, Journal of Innate Immunity.
[20] Wei Zhou,et al. Contribution of SDF-1α/CXCR4 Signaling to Brain Development and Glioma Progression , 2012, Neurosignals.
[21] G. Barton,et al. Anti-inflammatory role of IL-10 producing macrophages during early Brucella abortus infection , 2012 .
[22] E. Moreno,et al. What have we learned from brucellosis in the mouse model? , 2012, Veterinary Research.
[23] B. Samuelsson,et al. An Elucidation of the Arachidonic Acid Cascade , 2012, Drugs.
[24] R. Roop,et al. Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host , 2009, Medical Microbiology and Immunology.
[25] S. Amini,et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[26] R. Gazzinelli,et al. Central Role of MyD88-Dependent Dendritic Cell Maturation and Proinflammatory Cytokine Production to Control Brucella abortus Infection1 , 2008, The Journal of Immunology.
[27] X. Bian,et al. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. , 2006, Biochemical and biophysical research communications.
[28] M. Watarai,et al. Interferon-γ promotes abortion due to Brucella infection in pregnant mice , 2005, BMC Microbiology.
[29] P. Pasquali,et al. Effect of Exogenous Interleukin-18 (IL-18) and IL-12 in the Course of Brucella abortus 2308 Infection in Mice , 2002, Clinical and Vaccine Immunology.
[30] H. Showell,et al. Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[31] Hitoshi Shimano,et al. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. , 2002, Vitamins and hormones.
[32] B. Spellberg,et al. Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] E. Moreno,et al. Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. , 2000, Microbes and infection.
[34] R. Nelson,et al. Interleukin 12 deficiency associated with recurrent infections. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Horton,et al. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Young,et al. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor. , 1992, International journal of immunopharmacology.
[37] B. Samuelsson. An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes. , 1987, Drugs.
[38] J. Ferrendelli,et al. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. , 1977, Proceedings of the National Academy of Sciences of the United States of America.